nodes	percent_of_prediction	percent_of_DWPC	metapath
Meclofenamic acid—PTGS2—urinary bladder cancer	0.334	1	CbGaD
Meclofenamic acid—AKR1C3—Doxorubicin—urinary bladder cancer	0.191	0.425	CbGbCtD
Meclofenamic acid—SLCO1C1—Methotrexate—urinary bladder cancer	0.106	0.236	CbGbCtD
Meclofenamic acid—PTGS2—Cisplatin—urinary bladder cancer	0.0461	0.103	CbGbCtD
Meclofenamic acid—PTGS2—Etoposide—urinary bladder cancer	0.0453	0.101	CbGbCtD
Meclofenamic acid—PTGS1—Etoposide—urinary bladder cancer	0.0383	0.0853	CbGbCtD
Meclofenamic acid—SLC22A6—Methotrexate—urinary bladder cancer	0.0222	0.0494	CbGbCtD
Meclofenamic acid—AKR1C3—Podofilox—Etoposide—urinary bladder cancer	0.00362	1	CbGdCrCtD
Meclofenamic acid—AKR1C3—prostate gland—urinary bladder cancer	0.00284	0.0731	CbGeAlD
Meclofenamic acid—KCNQ3—female reproductive system—urinary bladder cancer	0.00264	0.0678	CbGeAlD
Meclofenamic acid—ALOX5—prostate gland—urinary bladder cancer	0.00251	0.0644	CbGeAlD
Meclofenamic acid—KCNQ2—female reproductive system—urinary bladder cancer	0.00243	0.0624	CbGeAlD
Meclofenamic acid—AKR1C3—seminal vesicle—urinary bladder cancer	0.0024	0.0618	CbGeAlD
Meclofenamic acid—SLCO1C1—renal system—urinary bladder cancer	0.00211	0.0542	CbGeAlD
Meclofenamic acid—AKR1C3—smooth muscle tissue—urinary bladder cancer	0.00201	0.0518	CbGeAlD
Meclofenamic acid—AKR1C3—urethra—urinary bladder cancer	0.0019	0.0489	CbGeAlD
Meclofenamic acid—ALOX5—smooth muscle tissue—urinary bladder cancer	0.00177	0.0456	CbGeAlD
Meclofenamic acid—ALOX5—urethra—urinary bladder cancer	0.00168	0.0431	CbGeAlD
Meclofenamic acid—Acetylsalicylic acid—TP53—urinary bladder cancer	0.00159	0.273	CrCbGaD
Meclofenamic acid—AKR1C3—vagina—urinary bladder cancer	0.0014	0.0361	CbGeAlD
Meclofenamic acid—Diclofenac—UGT2B7—urinary bladder cancer	0.00139	0.239	CrCbGaD
Meclofenamic acid—ALOX5—female reproductive system—urinary bladder cancer	0.00137	0.0352	CbGeAlD
Meclofenamic acid—PTGS1—prostate gland—urinary bladder cancer	0.00101	0.0259	CbGeAlD
Meclofenamic acid—SLCO1C1—lymph node—urinary bladder cancer	0.000988	0.0254	CbGeAlD
Meclofenamic acid—PTGS2—prostate gland—urinary bladder cancer	0.000961	0.0247	CbGeAlD
Meclofenamic acid—AKR1C3—lymph node—urinary bladder cancer	0.000908	0.0233	CbGeAlD
Meclofenamic acid—PTGS1—seminal vesicle—urinary bladder cancer	0.000851	0.0219	CbGeAlD
Meclofenamic acid—PTGS2—seminal vesicle—urinary bladder cancer	0.000813	0.0209	CbGeAlD
Meclofenamic acid—ALOX5—lymph node—urinary bladder cancer	0.0008	0.0206	CbGeAlD
Meclofenamic acid—Diclofenac—CXCL8—urinary bladder cancer	0.000788	0.135	CrCbGaD
Meclofenamic acid—Pruritus—Valrubicin—urinary bladder cancer	0.000781	0.00758	CcSEcCtD
Meclofenamic acid—Blindness—Epirubicin—urinary bladder cancer	0.00078	0.00757	CcSEcCtD
Meclofenamic acid—Oedema—Mitomycin—urinary bladder cancer	0.000761	0.00738	CcSEcCtD
Meclofenamic acid—Diarrhoea—Valrubicin—urinary bladder cancer	0.000755	0.00733	CcSEcCtD
Meclofenamic acid—PTGS1—epithelium—urinary bladder cancer	0.000739	0.019	CbGeAlD
Meclofenamic acid—Anorexia—Mitomycin—urinary bladder cancer	0.000725	0.00704	CcSEcCtD
Meclofenamic acid—Blindness—Doxorubicin—urinary bladder cancer	0.000721	0.007	CcSEcCtD
Meclofenamic acid—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000712	0.0183	CbGeAlD
Meclofenamic acid—PTGS2—epithelium—urinary bladder cancer	0.000706	0.0182	CbGeAlD
Meclofenamic acid—Vomiting—Valrubicin—urinary bladder cancer	0.000702	0.00681	CcSEcCtD
Meclofenamic acid—PTGS1—renal system—urinary bladder cancer	0.000686	0.0176	CbGeAlD
Meclofenamic acid—PTGS2—smooth muscle tissue—urinary bladder cancer	0.000681	0.0175	CbGeAlD
Meclofenamic acid—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.000676	0.00656	CcSEcCtD
Meclofenamic acid—Decreased appetite—Mitomycin—urinary bladder cancer	0.000661	0.00642	CcSEcCtD
Meclofenamic acid—Nausea—Valrubicin—urinary bladder cancer	0.000656	0.00636	CcSEcCtD
Meclofenamic acid—Fatigue—Mitomycin—urinary bladder cancer	0.000656	0.00636	CcSEcCtD
Meclofenamic acid—PTGS2—renal system—urinary bladder cancer	0.000655	0.0169	CbGeAlD
Meclofenamic acid—PTGS2—urethra—urinary bladder cancer	0.000644	0.0166	CbGeAlD
Meclofenamic acid—Feeling abnormal—Mitomycin—urinary bladder cancer	0.000627	0.00608	CcSEcCtD
Meclofenamic acid—Renal failure—Thiotepa—urinary bladder cancer	0.00059	0.00572	CcSEcCtD
Meclofenamic acid—Stomatitis—Thiotepa—urinary bladder cancer	0.000585	0.00567	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Thiotepa—urinary bladder cancer	0.000583	0.00566	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00056	0.00543	CcSEcCtD
Meclofenamic acid—Eosinophilia—Fluorouracil—urinary bladder cancer	0.000551	0.00535	CcSEcCtD
Meclofenamic acid—PTGS1—female reproductive system—urinary bladder cancer	0.000549	0.0141	CbGeAlD
Meclofenamic acid—Asthenia—Mitomycin—urinary bladder cancer	0.000546	0.0053	CcSEcCtD
Meclofenamic acid—Haemoglobin—Thiotepa—urinary bladder cancer	0.000541	0.00525	CcSEcCtD
Meclofenamic acid—Haemorrhage—Thiotepa—urinary bladder cancer	0.000538	0.00522	CcSEcCtD
Meclofenamic acid—Neutropenia—Gemcitabine—urinary bladder cancer	0.000529	0.00513	CcSEcCtD
Meclofenamic acid—Lumiracoxib—PTGS2—urinary bladder cancer	0.000528	0.0904	CrCbGaD
Meclofenamic acid—PTGS2—female reproductive system—urinary bladder cancer	0.000525	0.0135	CbGeAlD
Meclofenamic acid—Diarrhoea—Mitomycin—urinary bladder cancer	0.00052	0.00505	CcSEcCtD
Meclofenamic acid—Tinnitus—Thiotepa—urinary bladder cancer	0.000502	0.00487	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.0005	0.00485	CcSEcCtD
Meclofenamic acid—PTGS1—vagina—urinary bladder cancer	0.000497	0.0128	CbGeAlD
Meclofenamic acid—Renal failure—Gemcitabine—urinary bladder cancer	0.000496	0.00481	CcSEcCtD
Meclofenamic acid—Stomatitis—Gemcitabine—urinary bladder cancer	0.000492	0.00477	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.000491	0.00477	CcSEcCtD
Meclofenamic acid—Ulcer—Methotrexate—urinary bladder cancer	0.000488	0.00473	CcSEcCtD
Meclofenamic acid—Vomiting—Mitomycin—urinary bladder cancer	0.000484	0.00469	CcSEcCtD
Meclofenamic acid—Stomatitis—Fluorouracil—urinary bladder cancer	0.000484	0.00469	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Fluorouracil—urinary bladder cancer	0.000482	0.00468	CcSEcCtD
Meclofenamic acid—Alopecia—Thiotepa—urinary bladder cancer	0.000476	0.00462	CcSEcCtD
Meclofenamic acid—PTGS2—vagina—urinary bladder cancer	0.000475	0.0122	CbGeAlD
Meclofenamic acid—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.000471	0.00457	CcSEcCtD
Meclofenamic acid—Nocturia—Epirubicin—urinary bladder cancer	0.000465	0.00452	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.000463	0.00449	CcSEcCtD
Meclofenamic acid—Renal failure—Cisplatin—urinary bladder cancer	0.000462	0.00449	CcSEcCtD
Meclofenamic acid—Stomatitis—Cisplatin—urinary bladder cancer	0.000458	0.00445	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Cisplatin—urinary bladder cancer	0.000457	0.00444	CcSEcCtD
Meclofenamic acid—Ulcer—Epirubicin—urinary bladder cancer	0.000456	0.00443	CcSEcCtD
Meclofenamic acid—Haemoglobin—Gemcitabine—urinary bladder cancer	0.000455	0.00442	CcSEcCtD
Meclofenamic acid—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.000455	0.00441	CcSEcCtD
Meclofenamic acid—Haemorrhage—Gemcitabine—urinary bladder cancer	0.000453	0.00439	CcSEcCtD
Meclofenamic acid—Neutropenia—Etoposide—urinary bladder cancer	0.000452	0.00438	CcSEcCtD
Meclofenamic acid—Nausea—Mitomycin—urinary bladder cancer	0.000452	0.00438	CcSEcCtD
Meclofenamic acid—Haemoglobin—Fluorouracil—urinary bladder cancer	0.000448	0.00434	CcSEcCtD
Meclofenamic acid—Haemorrhage—Fluorouracil—urinary bladder cancer	0.000445	0.00432	CcSEcCtD
Meclofenamic acid—Vision blurred—Thiotepa—urinary bladder cancer	0.000442	0.00429	CcSEcCtD
Meclofenamic acid—Nocturia—Doxorubicin—urinary bladder cancer	0.000431	0.00418	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000428	0.00416	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.000427	0.00414	CcSEcCtD
Meclofenamic acid—Renal failure—Etoposide—urinary bladder cancer	0.000424	0.00411	CcSEcCtD
Meclofenamic acid—Ulcer—Doxorubicin—urinary bladder cancer	0.000422	0.0041	CcSEcCtD
Meclofenamic acid—Stomatitis—Etoposide—urinary bladder cancer	0.00042	0.00407	CcSEcCtD
Meclofenamic acid—Leukopenia—Thiotepa—urinary bladder cancer	0.00042	0.00407	CcSEcCtD
Meclofenamic acid—Salsalate—PTGS2—urinary bladder cancer	0.000417	0.0715	CrCbGaD
Meclofenamic acid—Colitis—Epirubicin—urinary bladder cancer	0.000415	0.00402	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Etoposide—urinary bladder cancer	0.000402	0.0039	CcSEcCtD
Meclofenamic acid—Alopecia—Gemcitabine—urinary bladder cancer	0.0004	0.00388	CcSEcCtD
Meclofenamic acid—Tinnitus—Cisplatin—urinary bladder cancer	0.000394	0.00382	CcSEcCtD
Meclofenamic acid—Alopecia—Fluorouracil—urinary bladder cancer	0.000394	0.00382	CcSEcCtD
Meclofenamic acid—Colitis—Doxorubicin—urinary bladder cancer	0.000384	0.00372	CcSEcCtD
Meclofenamic acid—Alopecia—Cisplatin—urinary bladder cancer	0.000373	0.00362	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000366	0.00355	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Etoposide—urinary bladder cancer	0.000366	0.00355	CcSEcCtD
Meclofenamic acid—Vision blurred—Fluorouracil—urinary bladder cancer	0.000365	0.00355	CcSEcCtD
Meclofenamic acid—Anorexia—Thiotepa—urinary bladder cancer	0.000365	0.00354	CcSEcCtD
Meclofenamic acid—Malaise—Gemcitabine—urinary bladder cancer	0.000356	0.00345	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000355	0.00344	CcSEcCtD
Meclofenamic acid—Leukopenia—Gemcitabine—urinary bladder cancer	0.000353	0.00342	CcSEcCtD
Meclofenamic acid—Leukopenia—Fluorouracil—urinary bladder cancer	0.000347	0.00337	CcSEcCtD
Meclofenamic acid—Vision blurred—Cisplatin—urinary bladder cancer	0.000346	0.00336	CcSEcCtD
Meclofenamic acid—Paraesthesia—Thiotepa—urinary bladder cancer	0.000343	0.00333	CcSEcCtD
Meclofenamic acid—Alopecia—Etoposide—urinary bladder cancer	0.000342	0.00332	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000341	0.00331	CcSEcCtD
Meclofenamic acid—Decreased appetite—Thiotepa—urinary bladder cancer	0.000333	0.00323	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000332	0.00322	CcSEcCtD
Meclofenamic acid—Discomfort—Gemcitabine—urinary bladder cancer	0.000332	0.00322	CcSEcCtD
Meclofenamic acid—Malaise—Cisplatin—urinary bladder cancer	0.000331	0.00322	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00033	0.0032	CcSEcCtD
Meclofenamic acid—Fatigue—Thiotepa—urinary bladder cancer	0.00033	0.0032	CcSEcCtD
Meclofenamic acid—Leukopenia—Cisplatin—urinary bladder cancer	0.000329	0.00319	CcSEcCtD
Meclofenamic acid—Constipation—Thiotepa—urinary bladder cancer	0.000327	0.00317	CcSEcCtD
Meclofenamic acid—Discomfort—Fluorouracil—urinary bladder cancer	0.000326	0.00316	CcSEcCtD
Meclofenamic acid—Oedema—Gemcitabine—urinary bladder cancer	0.000322	0.00312	CcSEcCtD
Meclofenamic acid—PTGS1—lymph node—urinary bladder cancer	0.000321	0.00826	CbGeAlD
Meclofenamic acid—Mefenamic acid—PTGS2—urinary bladder cancer	0.00032	0.0548	CrCbGaD
Meclofenamic acid—Oedema—Fluorouracil—urinary bladder cancer	0.000316	0.00307	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000315	0.00306	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000313	0.00304	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000312	0.00303	CcSEcCtD
Meclofenamic acid—Acetylsalicylic acid—PTGS2—urinary bladder cancer	0.000312	0.0534	CrCbGaD
Meclofenamic acid—Discomfort—Cisplatin—urinary bladder cancer	0.000309	0.003	CcSEcCtD
Meclofenamic acid—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000307	0.00298	CcSEcCtD
Meclofenamic acid—PTGS2—lymph node—urinary bladder cancer	0.000307	0.0079	CbGeAlD
Meclofenamic acid—Anorexia—Gemcitabine—urinary bladder cancer	0.000307	0.00298	CcSEcCtD
Meclofenamic acid—Urticaria—Thiotepa—urinary bladder cancer	0.000304	0.00295	CcSEcCtD
Meclofenamic acid—Malaise—Etoposide—urinary bladder cancer	0.000304	0.00295	CcSEcCtD
Meclofenamic acid—Abdominal pain—Thiotepa—urinary bladder cancer	0.000302	0.00293	CcSEcCtD
Meclofenamic acid—Anorexia—Fluorouracil—urinary bladder cancer	0.000302	0.00293	CcSEcCtD
Meclofenamic acid—Leukopenia—Etoposide—urinary bladder cancer	0.000301	0.00292	CcSEcCtD
Meclofenamic acid—Oedema—Cisplatin—urinary bladder cancer	0.0003	0.00291	CcSEcCtD
Meclofenamic acid—Insomnia—Gemcitabine—urinary bladder cancer	0.000291	0.00282	CcSEcCtD
Meclofenamic acid—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000289	0.0028	CcSEcCtD
Meclofenamic acid—Eosinophilia—Methotrexate—urinary bladder cancer	0.000287	0.00278	CcSEcCtD
Meclofenamic acid—Insomnia—Fluorouracil—urinary bladder cancer	0.000286	0.00278	CcSEcCtD
Meclofenamic acid—Anorexia—Cisplatin—urinary bladder cancer	0.000286	0.00277	CcSEcCtD
Meclofenamic acid—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000284	0.00276	CcSEcCtD
Meclofenamic acid—Discomfort—Etoposide—urinary bladder cancer	0.000283	0.00275	CcSEcCtD
Meclofenamic acid—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00028	0.00271	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000278	0.0027	CcSEcCtD
Meclofenamic acid—Fatigue—Gemcitabine—urinary bladder cancer	0.000277	0.00269	CcSEcCtD
Meclofenamic acid—Constipation—Gemcitabine—urinary bladder cancer	0.000275	0.00267	CcSEcCtD
Meclofenamic acid—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000275	0.00267	CcSEcCtD
Meclofenamic acid—Asthenia—Thiotepa—urinary bladder cancer	0.000274	0.00266	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000273	0.00265	CcSEcCtD
Meclofenamic acid—Neutropenia—Methotrexate—urinary bladder cancer	0.000271	0.00263	CcSEcCtD
Meclofenamic acid—Pruritus—Thiotepa—urinary bladder cancer	0.000271	0.00263	CcSEcCtD
Meclofenamic acid—Paraesthesia—Cisplatin—urinary bladder cancer	0.000269	0.00261	CcSEcCtD
Meclofenamic acid—Eosinophilia—Epirubicin—urinary bladder cancer	0.000268	0.0026	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000265	0.00257	CcSEcCtD
Meclofenamic acid—Anorexia—Etoposide—urinary bladder cancer	0.000262	0.00254	CcSEcCtD
Meclofenamic acid—Diarrhoea—Thiotepa—urinary bladder cancer	0.000262	0.00254	CcSEcCtD
Meclofenamic acid—Decreased appetite—Cisplatin—urinary bladder cancer	0.000261	0.00253	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000261	0.00253	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000259	0.00251	CcSEcCtD
Meclofenamic acid—Salicylic acid—PTGS2—urinary bladder cancer	0.000257	0.044	CrCbGaD
Meclofenamic acid—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000256	0.00248	CcSEcCtD
Meclofenamic acid—Renal failure—Methotrexate—urinary bladder cancer	0.000254	0.00246	CcSEcCtD
Meclofenamic acid—Neutropenia—Epirubicin—urinary bladder cancer	0.000253	0.00246	CcSEcCtD
Meclofenamic acid—Stomatitis—Methotrexate—urinary bladder cancer	0.000252	0.00244	CcSEcCtD
Meclofenamic acid—Urticaria—Fluorouracil—urinary bladder cancer	0.000251	0.00244	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000251	0.00243	CcSEcCtD
Meclofenamic acid—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000248	0.00241	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000247	0.0024	CcSEcCtD
Meclofenamic acid—Paraesthesia—Etoposide—urinary bladder cancer	0.000247	0.00239	CcSEcCtD
Meclofenamic acid—Vomiting—Thiotepa—urinary bladder cancer	0.000243	0.00236	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000241	0.00234	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000239	0.00232	CcSEcCtD
Meclofenamic acid—Decreased appetite—Etoposide—urinary bladder cancer	0.000239	0.00232	CcSEcCtD
Meclofenamic acid—Renal failure—Epirubicin—urinary bladder cancer	0.000237	0.0023	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000237	0.0023	CcSEcCtD
Meclofenamic acid—Fatigue—Etoposide—urinary bladder cancer	0.000237	0.0023	CcSEcCtD
Meclofenamic acid—Stomatitis—Epirubicin—urinary bladder cancer	0.000235	0.00228	CcSEcCtD
Meclofenamic acid—Constipation—Etoposide—urinary bladder cancer	0.000235	0.00228	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000235	0.00228	CcSEcCtD
Meclofenamic acid—Neutropenia—Doxorubicin—urinary bladder cancer	0.000234	0.00227	CcSEcCtD
Meclofenamic acid—Haemoglobin—Methotrexate—urinary bladder cancer	0.000233	0.00226	CcSEcCtD
Meclofenamic acid—Haemorrhage—Methotrexate—urinary bladder cancer	0.000232	0.00225	CcSEcCtD
Meclofenamic acid—Asthenia—Gemcitabine—urinary bladder cancer	0.000231	0.00224	CcSEcCtD
Meclofenamic acid—Diclofenac—PTGS2—urinary bladder cancer	0.00023	0.0394	CrCbGaD
Meclofenamic acid—Pruritus—Gemcitabine—urinary bladder cancer	0.000228	0.00221	CcSEcCtD
Meclofenamic acid—Nausea—Thiotepa—urinary bladder cancer	0.000227	0.0022	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Etoposide—urinary bladder cancer	0.000226	0.0022	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000225	0.00219	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000225	0.00218	CcSEcCtD
Meclofenamic acid—Pruritus—Fluorouracil—urinary bladder cancer	0.000224	0.00217	CcSEcCtD
Meclofenamic acid—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000222	0.00215	CcSEcCtD
Meclofenamic acid—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00022	0.00214	CcSEcCtD
Meclofenamic acid—Renal failure—Doxorubicin—urinary bladder cancer	0.00022	0.00213	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000219	0.00213	CcSEcCtD
Meclofenamic acid—Urticaria—Etoposide—urinary bladder cancer	0.000218	0.00212	CcSEcCtD
Meclofenamic acid—Haemoglobin—Epirubicin—urinary bladder cancer	0.000218	0.00211	CcSEcCtD
Meclofenamic acid—Stomatitis—Doxorubicin—urinary bladder cancer	0.000218	0.00211	CcSEcCtD
Meclofenamic acid—Abdominal pain—Etoposide—urinary bladder cancer	0.000217	0.00211	CcSEcCtD
Meclofenamic acid—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000217	0.00211	CcSEcCtD
Meclofenamic acid—Haemorrhage—Epirubicin—urinary bladder cancer	0.000217	0.0021	CcSEcCtD
Meclofenamic acid—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000216	0.0021	CcSEcCtD
Meclofenamic acid—Tinnitus—Methotrexate—urinary bladder cancer	0.000216	0.0021	CcSEcCtD
Meclofenamic acid—Asthenia—Cisplatin—urinary bladder cancer	0.000215	0.00209	CcSEcCtD
Meclofenamic acid—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000209	0.00202	CcSEcCtD
Meclofenamic acid—Diarrhoea—Cisplatin—urinary bladder cancer	0.000205	0.00199	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000205	0.00199	CcSEcCtD
Meclofenamic acid—Alopecia—Methotrexate—urinary bladder cancer	0.000205	0.00199	CcSEcCtD
Meclofenamic acid—Vomiting—Gemcitabine—urinary bladder cancer	0.000205	0.00199	CcSEcCtD
Meclofenamic acid—Tinnitus—Epirubicin—urinary bladder cancer	0.000202	0.00196	CcSEcCtD
Meclofenamic acid—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000202	0.00196	CcSEcCtD
Meclofenamic acid—Vomiting—Fluorouracil—urinary bladder cancer	0.000201	0.00195	CcSEcCtD
Meclofenamic acid—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000201	0.00195	CcSEcCtD
Meclofenamic acid—Asthenia—Etoposide—urinary bladder cancer	0.000197	0.00191	CcSEcCtD
Meclofenamic acid—Pruritus—Etoposide—urinary bladder cancer	0.000194	0.00189	CcSEcCtD
Meclofenamic acid—Alopecia—Epirubicin—urinary bladder cancer	0.000192	0.00186	CcSEcCtD
Meclofenamic acid—Nausea—Gemcitabine—urinary bladder cancer	0.000191	0.00185	CcSEcCtD
Meclofenamic acid—Vomiting—Cisplatin—urinary bladder cancer	0.000191	0.00185	CcSEcCtD
Meclofenamic acid—Vision blurred—Methotrexate—urinary bladder cancer	0.00019	0.00184	CcSEcCtD
Meclofenamic acid—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00019	0.00184	CcSEcCtD
Meclofenamic acid—Diarrhoea—Etoposide—urinary bladder cancer	0.000188	0.00182	CcSEcCtD
Meclofenamic acid—Nausea—Fluorouracil—urinary bladder cancer	0.000188	0.00182	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000187	0.00182	CcSEcCtD
Meclofenamic acid—Tinnitus—Doxorubicin—urinary bladder cancer	0.000187	0.00181	CcSEcCtD
Meclofenamic acid—Malaise—Methotrexate—urinary bladder cancer	0.000182	0.00176	CcSEcCtD
Meclofenamic acid—Leukopenia—Methotrexate—urinary bladder cancer	0.000181	0.00175	CcSEcCtD
Meclofenamic acid—Nausea—Cisplatin—urinary bladder cancer	0.000178	0.00173	CcSEcCtD
Meclofenamic acid—Vision blurred—Epirubicin—urinary bladder cancer	0.000178	0.00173	CcSEcCtD
Meclofenamic acid—Alopecia—Doxorubicin—urinary bladder cancer	0.000177	0.00172	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000175	0.0017	CcSEcCtD
Meclofenamic acid—Vomiting—Etoposide—urinary bladder cancer	0.000175	0.0017	CcSEcCtD
Meclofenamic acid—Malaise—Epirubicin—urinary bladder cancer	0.00017	0.00165	CcSEcCtD
Meclofenamic acid—Discomfort—Methotrexate—urinary bladder cancer	0.00017	0.00165	CcSEcCtD
Meclofenamic acid—Leukopenia—Epirubicin—urinary bladder cancer	0.000169	0.00164	CcSEcCtD
Meclofenamic acid—Palpitations—Epirubicin—urinary bladder cancer	0.000167	0.00162	CcSEcCtD
Meclofenamic acid—Vision blurred—Doxorubicin—urinary bladder cancer	0.000165	0.0016	CcSEcCtD
Meclofenamic acid—Nausea—Etoposide—urinary bladder cancer	0.000163	0.00158	CcSEcCtD
Meclofenamic acid—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000162	0.00157	CcSEcCtD
Meclofenamic acid—Discomfort—Epirubicin—urinary bladder cancer	0.000159	0.00154	CcSEcCtD
Meclofenamic acid—Malaise—Doxorubicin—urinary bladder cancer	0.000157	0.00153	CcSEcCtD
Meclofenamic acid—Anorexia—Methotrexate—urinary bladder cancer	0.000157	0.00152	CcSEcCtD
Meclofenamic acid—Leukopenia—Doxorubicin—urinary bladder cancer	0.000156	0.00152	CcSEcCtD
Meclofenamic acid—Palpitations—Doxorubicin—urinary bladder cancer	0.000154	0.0015	CcSEcCtD
Meclofenamic acid—Oedema—Epirubicin—urinary bladder cancer	0.000154	0.00149	CcSEcCtD
Meclofenamic acid—Insomnia—Methotrexate—urinary bladder cancer	0.000149	0.00144	CcSEcCtD
Meclofenamic acid—Paraesthesia—Methotrexate—urinary bladder cancer	0.000148	0.00143	CcSEcCtD
Meclofenamic acid—Discomfort—Doxorubicin—urinary bladder cancer	0.000147	0.00143	CcSEcCtD
Meclofenamic acid—Anorexia—Epirubicin—urinary bladder cancer	0.000147	0.00142	CcSEcCtD
Meclofenamic acid—Decreased appetite—Methotrexate—urinary bladder cancer	0.000143	0.00139	CcSEcCtD
Meclofenamic acid—Oedema—Doxorubicin—urinary bladder cancer	0.000143	0.00138	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000142	0.00138	CcSEcCtD
Meclofenamic acid—Fatigue—Methotrexate—urinary bladder cancer	0.000142	0.00138	CcSEcCtD
Meclofenamic acid—Insomnia—Epirubicin—urinary bladder cancer	0.000139	0.00135	CcSEcCtD
Meclofenamic acid—Paraesthesia—Epirubicin—urinary bladder cancer	0.000138	0.00134	CcSEcCtD
Meclofenamic acid—Anorexia—Doxorubicin—urinary bladder cancer	0.000136	0.00132	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000136	0.00132	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000135	0.00131	CcSEcCtD
Meclofenamic acid—Decreased appetite—Epirubicin—urinary bladder cancer	0.000134	0.0013	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000133	0.00129	CcSEcCtD
Meclofenamic acid—Fatigue—Epirubicin—urinary bladder cancer	0.000133	0.00129	CcSEcCtD
Meclofenamic acid—Constipation—Epirubicin—urinary bladder cancer	0.000132	0.00128	CcSEcCtD
Meclofenamic acid—Urticaria—Methotrexate—urinary bladder cancer	0.000131	0.00127	CcSEcCtD
Meclofenamic acid—Abdominal pain—Methotrexate—urinary bladder cancer	0.00013	0.00126	CcSEcCtD
Meclofenamic acid—Insomnia—Doxorubicin—urinary bladder cancer	0.000129	0.00125	CcSEcCtD
Meclofenamic acid—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000128	0.00124	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000127	0.00123	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000126	0.00122	CcSEcCtD
Meclofenamic acid—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000124	0.0012	CcSEcCtD
Meclofenamic acid—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000123	0.00119	CcSEcCtD
Meclofenamic acid—Fatigue—Doxorubicin—urinary bladder cancer	0.000123	0.00119	CcSEcCtD
Meclofenamic acid—Urticaria—Epirubicin—urinary bladder cancer	0.000122	0.00119	CcSEcCtD
Meclofenamic acid—Constipation—Doxorubicin—urinary bladder cancer	0.000122	0.00118	CcSEcCtD
Meclofenamic acid—Abdominal pain—Epirubicin—urinary bladder cancer	0.000122	0.00118	CcSEcCtD
Meclofenamic acid—Asthenia—Methotrexate—urinary bladder cancer	0.000118	0.00115	CcSEcCtD
Meclofenamic acid—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000117	0.00114	CcSEcCtD
Meclofenamic acid—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000117	0.00113	CcSEcCtD
Meclofenamic acid—Pruritus—Methotrexate—urinary bladder cancer	0.000116	0.00113	CcSEcCtD
Meclofenamic acid—Urticaria—Doxorubicin—urinary bladder cancer	0.000113	0.0011	CcSEcCtD
Meclofenamic acid—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000113	0.00109	CcSEcCtD
Meclofenamic acid—Diarrhoea—Methotrexate—urinary bladder cancer	0.000113	0.00109	CcSEcCtD
Meclofenamic acid—Asthenia—Epirubicin—urinary bladder cancer	0.000111	0.00107	CcSEcCtD
Meclofenamic acid—Pruritus—Epirubicin—urinary bladder cancer	0.000109	0.00106	CcSEcCtD
Meclofenamic acid—Diarrhoea—Epirubicin—urinary bladder cancer	0.000105	0.00102	CcSEcCtD
Meclofenamic acid—Vomiting—Methotrexate—urinary bladder cancer	0.000105	0.00102	CcSEcCtD
Meclofenamic acid—Asthenia—Doxorubicin—urinary bladder cancer	0.000102	0.000992	CcSEcCtD
Meclofenamic acid—Pruritus—Doxorubicin—urinary bladder cancer	0.000101	0.000978	CcSEcCtD
Meclofenamic acid—Vomiting—Epirubicin—urinary bladder cancer	9.79e-05	0.00095	CcSEcCtD
Meclofenamic acid—Nausea—Methotrexate—urinary bladder cancer	9.78e-05	0.000949	CcSEcCtD
Meclofenamic acid—Diarrhoea—Doxorubicin—urinary bladder cancer	9.75e-05	0.000946	CcSEcCtD
Meclofenamic acid—Nausea—Epirubicin—urinary bladder cancer	9.15e-05	0.000888	CcSEcCtD
Meclofenamic acid—Vomiting—Doxorubicin—urinary bladder cancer	9.06e-05	0.000879	CcSEcCtD
Meclofenamic acid—Nausea—Doxorubicin—urinary bladder cancer	8.47e-05	0.000821	CcSEcCtD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CDK4—urinary bladder cancer	8.13e-05	0.00123	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.12e-05	0.00122	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—ERBB2—urinary bladder cancer	7.9e-05	0.00119	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—ERBB2—urinary bladder cancer	7.9e-05	0.00119	CbGpPWpGaD
Meclofenamic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—urinary bladder cancer	7.8e-05	0.00118	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—NAT2—urinary bladder cancer	7.67e-05	0.00116	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—EGFR—urinary bladder cancer	7.67e-05	0.00116	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—EGFR—urinary bladder cancer	7.67e-05	0.00116	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NAT2—urinary bladder cancer	7.64e-05	0.00115	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ENO2—urinary bladder cancer	7.3e-05	0.0011	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—KRAS—urinary bladder cancer	7.25e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—KRAS—urinary bladder cancer	7.25e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.23e-05	0.00109	CbGpPWpGaD
Meclofenamic acid—SLCO1C1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.14e-05	0.00108	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.1e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—RB1—urinary bladder cancer	7.07e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—GLI1—urinary bladder cancer	7.07e-05	0.00107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.03e-05	0.00106	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Neuronal System—HRAS—urinary bladder cancer	6.94e-05	0.00105	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Neuronal System—HRAS—urinary bladder cancer	6.94e-05	0.00105	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RBX1—urinary bladder cancer	6.92e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CCND1—urinary bladder cancer	6.89e-05	0.00104	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—MMP9—urinary bladder cancer	6.77e-05	0.00102	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—MMP9—urinary bladder cancer	6.77e-05	0.00102	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—CDKN1A—urinary bladder cancer	6.67e-05	0.00101	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—RRM2—urinary bladder cancer	6.62e-05	0.000999	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—RRM2—urinary bladder cancer	6.6e-05	0.000996	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—RHOA—urinary bladder cancer	6.42e-05	0.000969	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—EP300—urinary bladder cancer	6.42e-05	0.000969	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—EP300—urinary bladder cancer	6.42e-05	0.000969	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	6.41e-05	0.000966	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.38e-05	0.000962	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—EP300—urinary bladder cancer	6.35e-05	0.000957	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.29e-05	0.000949	CbGpPWpGaD
Meclofenamic acid—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	6.25e-05	0.000943	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—SRC—urinary bladder cancer	6.24e-05	0.000942	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—SRC—urinary bladder cancer	6.24e-05	0.000942	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—JAG1—urinary bladder cancer	6.19e-05	0.000934	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Axon guidance—HRAS—urinary bladder cancer	6.16e-05	0.000929	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Axon guidance—HRAS—urinary bladder cancer	6.16e-05	0.000929	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—HPGDS—urinary bladder cancer	6.13e-05	0.000926	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ENO2—urinary bladder cancer	6.13e-05	0.000926	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—HPGDS—urinary bladder cancer	6.11e-05	0.000922	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ENO2—urinary bladder cancer	6.11e-05	0.000922	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.1e-05	0.00092	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.08e-05	0.000917	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTO2—urinary bladder cancer	6.07e-05	0.000916	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NAT1—urinary bladder cancer	6.07e-05	0.000916	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.97e-05	0.000901	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTT1—urinary bladder cancer	5.95e-05	0.000898	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTT1—urinary bladder cancer	5.93e-05	0.000894	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.86e-05	0.000884	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.84e-05	0.000881	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—GSTO2—urinary bladder cancer	5.76e-05	0.000868	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CXCL8—urinary bladder cancer	5.64e-05	0.000851	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.56e-05	0.000838	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	5.55e-05	0.000838	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.53e-05	0.000835	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—MYC—urinary bladder cancer	5.53e-05	0.000834	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.51e-05	0.000831	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—EGFR—urinary bladder cancer	5.47e-05	0.000826	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—EGFR—urinary bladder cancer	5.47e-05	0.000826	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—IL2—urinary bladder cancer	5.39e-05	0.000813	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—CCND1—urinary bladder cancer	5.25e-05	0.000793	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—TNF—urinary bladder cancer	5.21e-05	0.000786	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—TNF—urinary bladder cancer	5.21e-05	0.000786	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—KRAS—urinary bladder cancer	5.17e-05	0.00078	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—KRAS—urinary bladder cancer	5.17e-05	0.00078	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—KRAS—urinary bladder cancer	5.11e-05	0.000771	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MMP9—urinary bladder cancer	5.1e-05	0.000769	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTZ1—urinary bladder cancer	5.09e-05	0.000767	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	5e-05	0.000754	CbGpPWpGaD
Meclofenamic acid—PTGS2—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.96e-05	0.000749	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—NQO1—urinary bladder cancer	4.95e-05	0.000746	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NQO1—urinary bladder cancer	4.93e-05	0.000743	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RBX1—urinary bladder cancer	4.84e-05	0.000731	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.83e-05	0.000729	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTO2—urinary bladder cancer	4.82e-05	0.000727	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NAT1—urinary bladder cancer	4.82e-05	0.000727	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.8e-05	0.000724	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.78e-05	0.000721	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.77e-05	0.00072	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.74e-05	0.000715	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	4.72e-05	0.000713	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PRSS3—urinary bladder cancer	4.6e-05	0.000694	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TSC1—urinary bladder cancer	4.55e-05	0.000687	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—NCOR1—urinary bladder cancer	4.51e-05	0.00068	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SLC19A1—urinary bladder cancer	4.48e-05	0.000675	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—UGT2B7—urinary bladder cancer	4.41e-05	0.000665	CbGpPWpGaD
Meclofenamic acid—KCNQ2—Developmental Biology—HRAS—urinary bladder cancer	4.39e-05	0.000663	CbGpPWpGaD
Meclofenamic acid—KCNQ3—Developmental Biology—HRAS—urinary bladder cancer	4.39e-05	0.000663	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PRSS3—urinary bladder cancer	4.36e-05	0.000658	CbGpPWpGaD
Meclofenamic acid—PTGS2—C-MYB transcription factor network—HRAS—urinary bladder cancer	4.34e-05	0.000655	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—JAG1—urinary bladder cancer	4.34e-05	0.000654	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERCC2—urinary bladder cancer	4.24e-05	0.000639	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—MYC—urinary bladder cancer	4.21e-05	0.000636	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.18e-05	0.000631	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.17e-05	0.000629	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HDAC4—urinary bladder cancer	4.16e-05	0.000628	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTP1—urinary bladder cancer	4.12e-05	0.000622	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—EGFR—urinary bladder cancer	4.12e-05	0.000622	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTP1—urinary bladder cancer	4.11e-05	0.00062	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.04e-05	0.00061	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.99e-05	0.000602	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MTHFR—urinary bladder cancer	3.98e-05	0.000601	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.98e-05	0.0006	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—TERT—urinary bladder cancer	3.97e-05	0.000599	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CYP4B1—urinary bladder cancer	3.97e-05	0.000599	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TNF—urinary bladder cancer	3.92e-05	0.000592	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—TYMS—urinary bladder cancer	3.83e-05	0.000578	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—TYMS—urinary bladder cancer	3.82e-05	0.000576	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GSTM1—urinary bladder cancer	3.79e-05	0.000572	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—NCOR1—urinary bladder cancer	3.79e-05	0.000572	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GSTM1—urinary bladder cancer	3.78e-05	0.00057	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—NCOR1—urinary bladder cancer	3.78e-05	0.00057	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—SLC19A1—urinary bladder cancer	3.75e-05	0.000566	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.69e-05	0.000557	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TYMP—urinary bladder cancer	3.68e-05	0.000555	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PRSS3—urinary bladder cancer	3.65e-05	0.000551	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—FGFR3—urinary bladder cancer	3.65e-05	0.00055	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—GPX1—urinary bladder cancer	3.63e-05	0.000548	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—GPX1—urinary bladder cancer	3.62e-05	0.000545	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.57e-05	0.000539	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—ERCC2—urinary bladder cancer	3.56e-05	0.000538	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—ERCC2—urinary bladder cancer	3.55e-05	0.000536	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.53e-05	0.000533	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—S100B—urinary bladder cancer	3.51e-05	0.00053	CbGpPWpGaD
Meclofenamic acid—PTGS2—Spinal Cord Injury—TP53—urinary bladder cancer	3.46e-05	0.000522	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.46e-05	0.000522	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.45e-05	0.00052	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—MTHFR—urinary bladder cancer	3.35e-05	0.000505	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—MTHFR—urinary bladder cancer	3.34e-05	0.000503	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NAT2—urinary bladder cancer	3.33e-05	0.000502	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—LIG1—urinary bladder cancer	3.31e-05	0.000499	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.29e-05	0.000496	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.2e-05	0.000483	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—NCOR1—urinary bladder cancer	3.16e-05	0.000476	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CREBBP—urinary bladder cancer	3.1e-05	0.000468	CbGpPWpGaD
Meclofenamic acid—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.98e-05	0.00045	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.93e-05	0.000442	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TYMP—urinary bladder cancer	2.92e-05	0.000441	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—RRM2—urinary bladder cancer	2.87e-05	0.000433	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.87e-05	0.000432	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—RHOA—urinary bladder cancer	2.81e-05	0.000424	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.81e-05	0.000423	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.8e-05	0.000423	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TERT—urinary bladder cancer	2.78e-05	0.00042	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PPARG—urinary bladder cancer	2.72e-05	0.00041	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PPARG—urinary bladder cancer	2.71e-05	0.000408	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.67e-05	0.000403	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—HPGDS—urinary bladder cancer	2.66e-05	0.000401	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ENO2—urinary bladder cancer	2.66e-05	0.000401	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.65e-05	0.0004	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.64e-05	0.000399	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NAT2—urinary bladder cancer	2.64e-05	0.000399	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—CREBBP—urinary bladder cancer	2.61e-05	0.000394	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—CREBBP—urinary bladder cancer	2.6e-05	0.000392	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—ERBB2—urinary bladder cancer	2.6e-05	0.000392	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTT1—urinary bladder cancer	2.58e-05	0.000389	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—FGFR3—urinary bladder cancer	2.55e-05	0.000385	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTGS2—urinary bladder cancer	2.54e-05	0.000383	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.54e-05	0.000383	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ENO2—urinary bladder cancer	2.52e-05	0.00038	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ESR1—urinary bladder cancer	2.48e-05	0.000374	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RBX1—urinary bladder cancer	2.39e-05	0.000361	CbGpPWpGaD
Meclofenamic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.35e-05	0.000355	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—RRM2—urinary bladder cancer	2.28e-05	0.000344	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—CDKN1A—urinary bladder cancer	2.22e-05	0.000335	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—PTEN—urinary bladder cancer	2.22e-05	0.000334	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CREBBP—urinary bladder cancer	2.17e-05	0.000328	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IGF1—urinary bladder cancer	2.15e-05	0.000324	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.14e-05	0.000323	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—JAG1—urinary bladder cancer	2.14e-05	0.000323	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTGS2—urinary bladder cancer	2.14e-05	0.000322	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTGS2—urinary bladder cancer	2.13e-05	0.000321	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EP300—urinary bladder cancer	2.11e-05	0.000319	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—HPGDS—urinary bladder cancer	2.11e-05	0.000319	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ENO2—urinary bladder cancer	2.11e-05	0.000319	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.1e-05	0.000317	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.08e-05	0.000314	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—SRC—urinary bladder cancer	2.06e-05	0.00031	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTT1—urinary bladder cancer	2.05e-05	0.000309	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.02e-05	0.000304	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—RHOA—urinary bladder cancer	1.97e-05	0.000297	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—PTEN—urinary bladder cancer	1.86e-05	0.000281	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—PTEN—urinary bladder cancer	1.86e-05	0.00028	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—MYC—urinary bladder cancer	1.84e-05	0.000278	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—ERBB2—urinary bladder cancer	1.82e-05	0.000275	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.81e-05	0.000274	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—EGFR—urinary bladder cancer	1.8e-05	0.000272	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTP1—urinary bladder cancer	1.79e-05	0.00027	CbGpPWpGaD
Meclofenamic acid—ALOX5—Metabolism—EP300—urinary bladder cancer	1.78e-05	0.000268	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Metabolism—EP300—urinary bladder cancer	1.77e-05	0.000267	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.73e-05	0.000261	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CXCL8—urinary bladder cancer	1.73e-05	0.00026	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NQO1—urinary bladder cancer	1.7e-05	0.000257	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—KRAS—urinary bladder cancer	1.7e-05	0.000257	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—TYMS—urinary bladder cancer	1.66e-05	0.000251	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—IL2—urinary bladder cancer	1.65e-05	0.000249	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GSTM1—urinary bladder cancer	1.64e-05	0.000248	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—NCOR1—urinary bladder cancer	1.64e-05	0.000248	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CCND1—urinary bladder cancer	1.61e-05	0.000243	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.57e-05	0.000237	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MMP9—urinary bladder cancer	1.56e-05	0.000236	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—NCOR1—urinary bladder cancer	1.56e-05	0.000235	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—CDKN1A—urinary bladder cancer	1.56e-05	0.000235	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—PTEN—urinary bladder cancer	1.55e-05	0.000234	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.55e-05	0.000233	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EP300—urinary bladder cancer	1.48e-05	0.000223	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERCC2—urinary bladder cancer	1.46e-05	0.000221	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.45e-05	0.000219	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Disease—HRAS—urinary bladder cancer	1.45e-05	0.000218	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.44e-05	0.000217	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—SRC—urinary bladder cancer	1.44e-05	0.000217	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTP1—urinary bladder cancer	1.42e-05	0.000214	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MTHFR—urinary bladder cancer	1.38e-05	0.000208	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.37e-05	0.000207	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—TERT—urinary bladder cancer	1.37e-05	0.000207	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—TYMS—urinary bladder cancer	1.32e-05	0.000199	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	0.000197	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	0.000197	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—MYC—urinary bladder cancer	1.29e-05	0.000195	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—EGFR—urinary bladder cancer	1.26e-05	0.00019	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—FGFR3—urinary bladder cancer	1.26e-05	0.00019	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—GPX1—urinary bladder cancer	1.25e-05	0.000188	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—ERCC2—urinary bladder cancer	1.23e-05	0.000185	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—KRAS—urinary bladder cancer	1.19e-05	0.00018	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.18e-05	0.000178	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	0.000174	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.13e-05	0.000171	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CREBBP—urinary bladder cancer	1.07e-05	0.000162	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—TP53—urinary bladder cancer	1.06e-05	0.00016	CbGpPWpGaD
Meclofenamic acid—AKR1C3—Signaling Pathways—HRAS—urinary bladder cancer	1.01e-05	0.000153	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—RHOA—urinary bladder cancer	9.7e-06	0.000146	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PPARG—urinary bladder cancer	9.35e-06	0.000141	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTGS2—urinary bladder cancer	9.27e-06	0.00014	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—CREBBP—urinary bladder cancer	8.98e-06	0.000136	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—ERBB2—urinary bladder cancer	8.98e-06	0.000136	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—PTEN—urinary bladder cancer	8.08e-06	0.000122	CbGpPWpGaD
Meclofenamic acid—PTGS1—Metabolism—EP300—urinary bladder cancer	7.71e-06	0.000116	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—CDKN1A—urinary bladder cancer	7.68e-06	0.000116	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—PTEN—urinary bladder cancer	7.66e-06	0.000116	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EP300—urinary bladder cancer	7.3e-06	0.00011	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—SRC—urinary bladder cancer	7.1e-06	0.000107	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—PTEN—urinary bladder cancer	6.41e-06	9.68e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—MYC—urinary bladder cancer	6.36e-06	9.6e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—EGFR—urinary bladder cancer	6.23e-06	9.39e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Metabolism—EP300—urinary bladder cancer	6.12e-06	9.23e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—KRAS—urinary bladder cancer	5.88e-06	8.87e-05	CbGpPWpGaD
Meclofenamic acid—PTGS2—Disease—HRAS—urinary bladder cancer	5e-06	7.54e-05	CbGpPWpGaD
